Deadline Alert: Join Class Action Lawsuit Against BIOA by March 10, 2025 – Contact Levi & Korsinsky
Investors who purchased shares of BioAge Labs, Inc. (NASDAQ: BIOA) between its September 26, 2024, initial public offering (IPO) and January 7, 2025, may be eligible to join a class action lawsuit filed by law firm Levi & Korsinsky. The lawsuit, which accuses BioAge of misrepresenting the safety of its lead drug candidate, azelaprag, is … Read more